Annual Cash & Cash Equivalents
$3.69 M
-$2.89 M-43.89%
31 December 2023
Summary:
Trinity Biotech annual cash & cash equivalents is currently $3.69 million, with the most recent change of -$2.89 million (-43.89%) on 31 December 2023. During the last 3 years, it has fallen by -$23.64 million (-86.49%). TRIB annual cash & cash equivalents is now -96.38% below its all-time high of $101.95 million, reached on 31 December 2015.TRIB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
N/A
30 September 2024
Summary:
Trinity Biotech quarterly cash and cash equivalents is not available.TRIB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.9% | - |
| 3 y3 years | -86.5% | - |
| 5 y5 years | -87.8% | - |
TRIB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -86.5% | at low | ||
| 5 y | 5 years | -87.8% | at low | ||
| alltime | all time | -96.4% | +1130.3% |
Trinity Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $5.32 M(+44.1%) |
| Dec 2023 | $3.69 M(-43.9%) | $3.69 M(-43.9%) |
| Dec 2022 | $6.58 M(-74.6%) | $6.58 M(-37.1%) |
| June 2022 | - | $10.45 M(+4.4%) |
| Mar 2022 | - | $10.01 M(-61.4%) |
| Dec 2021 | $25.91 M(-5.2%) | $25.91 M(-19.7%) |
| Mar 2021 | - | $32.28 M(+18.1%) |
| Dec 2020 | $27.33 M(+79.4%) | $27.33 M(+37.3%) |
| Sept 2020 | - | $19.91 M(+50.3%) |
| Mar 2020 | - | $13.24 M(-13.0%) |
| Dec 2019 | $15.23 M(-49.7%) | $15.23 M(-39.3%) |
| Sept 2019 | - | $25.09 M(+0.4%) |
| June 2019 | - | $24.99 M(-15.1%) |
| Mar 2019 | - | $29.43 M(-2.8%) |
| Dec 2018 | $30.28 M(+28.5%) | $30.28 M(-15.1%) |
| Sept 2018 | - | $35.68 M(-27.8%) |
| June 2018 | - | $49.43 M(-8.3%) |
| Mar 2018 | - | $53.90 M(+128.7%) |
| Dec 2017 | $23.56 M(-69.4%) | $23.56 M(-62.3%) |
| Sept 2017 | - | $62.53 M(-2.3%) |
| June 2017 | - | $63.98 M(-8.4%) |
| Mar 2017 | - | $69.85 M(-9.4%) |
| Dec 2016 | $77.11 M(-24.4%) | $77.11 M(-9.0%) |
| Sept 2016 | - | $84.75 M(-0.2%) |
| June 2016 | - | $84.92 M(-12.3%) |
| Mar 2016 | - | $96.83 M(-5.0%) |
| Dec 2015 | $101.95 M(+1020.1%) | $101.95 M(-2.2%) |
| Sept 2015 | - | $104.29 M(-5.4%) |
| June 2015 | - | $110.26 M(+1819.2%) |
| Mar 2015 | - | $5.75 M(-36.9%) |
| Dec 2014 | $9.10 M(-59.2%) | $9.10 M(+1.7%) |
| Sept 2014 | - | $8.95 M(-40.9%) |
| June 2014 | - | $15.15 M(-10.9%) |
| Mar 2014 | - | $17.01 M(-23.8%) |
| Dec 2013 | $22.32 M(-70.2%) | $22.32 M(-16.7%) |
| Sept 2013 | - | $26.81 M(-59.5%) |
| June 2013 | - | $66.16 M(-9.5%) |
| Mar 2013 | - | $73.09 M(-2.5%) |
| Dec 2012 | $74.95 M(+5.4%) | $74.95 M(+0.7%) |
| Sept 2012 | - | $74.45 M(+1.2%) |
| June 2012 | - | $73.61 M(+12.4%) |
| Mar 2012 | - | $65.50 M(-7.9%) |
| Dec 2011 | $71.08 M(+22.6%) | $71.08 M(-0.1%) |
| Sept 2011 | - | $71.13 M(-0.4%) |
| June 2011 | - | $71.42 M(+19.4%) |
| Mar 2011 | - | $59.82 M(+3.1%) |
| Dec 2010 | $58.00 M(+854.3%) | $58.00 M(+7.8%) |
| Sept 2010 | - | $53.80 M(+7.5%) |
| June 2010 | - | $50.04 M(+704.3%) |
| Mar 2010 | - | $6.22 M(+2.4%) |
| Dec 2009 | $6.08 M | $6.08 M(+64.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2009 | - | $3.70 M(-22.8%) |
| June 2009 | - | $4.79 M(+85.1%) |
| Mar 2009 | - | $2.59 M(-50.1%) |
| Dec 2008 | $5.18 M(-40.4%) | $5.18 M(+48.0%) |
| Sept 2008 | - | $3.50 M(-43.9%) |
| June 2008 | - | $6.25 M(+103.1%) |
| Mar 2008 | - | $3.08 M(-64.7%) |
| Dec 2007 | $8.70 M(+208.4%) | $8.70 M(-4.1%) |
| June 2007 | - | $9.07 M(-32.9%) |
| Mar 2007 | - | $13.53 M(+379.4%) |
| Dec 2006 | $2.82 M(-42.6%) | $2.82 M(-38.3%) |
| Sept 2006 | - | $4.57 M(+50.5%) |
| June 2006 | - | $3.04 M(+301.2%) |
| Mar 2006 | - | $757.00 K(-84.6%) |
| Dec 2005 | $4.92 M(-77.9%) | $4.92 M(-74.5%) |
| Sept 2005 | - | $19.29 M(+7.4%) |
| June 2005 | - | $17.95 M(+4.5%) |
| Mar 2005 | - | $17.18 M(-22.9%) |
| Dec 2004 | $22.29 M(+8.4%) | $22.29 M(+30.5%) |
| Sept 2004 | - | $17.08 M(-33.2%) |
| June 2004 | - | $25.58 M(-41.9%) |
| Mar 2004 | - | $44.04 M(+114.2%) |
| Dec 2003 | $20.56 M(+254.1%) | $20.56 M(-0.7%) |
| Sept 2003 | - | $20.71 M(+1188.2%) |
| June 2003 | - | $1.61 M(-61.9%) |
| Mar 2003 | - | $4.22 M(-27.4%) |
| Dec 2002 | $5.81 M(+9.9%) | $5.81 M(+7.1%) |
| Sept 2002 | - | $5.42 M(+24.0%) |
| June 2002 | - | $4.37 M(-29.5%) |
| Mar 2002 | - | $6.21 M(+17.5%) |
| Dec 2001 | $5.28 M(+23.5%) | $5.28 M(-2.5%) |
| Sept 2001 | - | $5.42 M(-13.2%) |
| June 2001 | - | $6.24 M(+62.4%) |
| Mar 2001 | - | $3.84 M(-10.1%) |
| Dec 2000 | $4.28 M(+39.5%) | $4.28 M(-56.8%) |
| Sept 2000 | - | $9.90 M(-9.5%) |
| June 2000 | - | $10.95 M(+161.7%) |
| Mar 2000 | - | $4.18 M(+36.5%) |
| Dec 1999 | $3.06 M(+135.7%) | $3.06 M(+155.4%) |
| Sept 1999 | - | $1.20 M(0.0%) |
| June 1999 | - | $1.20 M(+20.0%) |
| Mar 1999 | - | $1.00 M(-23.1%) |
| Dec 1998 | $1.30 M(-53.6%) | $1.30 M(-58.1%) |
| Sept 1998 | - | $3.10 M(+181.8%) |
| June 1998 | - | $1.10 M(-60.7%) |
| Dec 1997 | $2.80 M(-42.9%) | $2.80 M(-42.9%) |
| Dec 1996 | $4.90 M(-34.7%) | $4.90 M(-34.7%) |
| Dec 1995 | $7.50 M(+2400.0%) | $7.50 M(+733.3%) |
| Dec 1994 | $300.00 K(-66.7%) | - |
| Feb 1994 | - | $900.00 K |
| Feb 1994 | $900.00 K | - |
FAQ
- What is Trinity Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Trinity Biotech?
- What is Trinity Biotech annual cash & cash equivalents year-on-year change?
- What is the all time high quarterly cash and cash equivalents for Trinity Biotech?
What is Trinity Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of TRIB is $3.69 M
What is the all time high annual cash & cash equivalents for Trinity Biotech?
Trinity Biotech all-time high annual cash & cash equivalents is $101.95 M
What is Trinity Biotech annual cash & cash equivalents year-on-year change?
Over the past year, TRIB annual cash & cash equivalents has changed by -$2.89 M (-43.89%)
What is the all time high quarterly cash and cash equivalents for Trinity Biotech?
Trinity Biotech all-time high quarterly cash and cash equivalents is $110.26 M